Acesso livre
Acesso livre

Medicina de Emergências

Estudo laboratorial mostra que novas pílulas antivirais mantêm sua eficácia contra a variante Ômicron, mas anticorpos monoclonais são substancialmente menos efetivos.

28 Jan, 2022 | 16:28h

Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant – New England Journal of Medicine

Comentário: Current anti-COVID pills work well against omicron, but antibody drugs are less effective, study finds – University of Wisconsin-Madison

 

Comentário no Twitter

 

Ampla revisão do tratamento com dreno torácico.

28 Jan, 2022 | 16:16h

Comprehensive Review of Chest Tube Management – JAMA Surgery (gratuito por tempo limitado)

Controvérsias e falta de evidências sobre o tratamento inicial da lesão cerebral traumática grave: de volta ao básico.

28 Jan, 2022 | 16:04h

Controversies and evidence gaps in the early management of severe traumatic brain injury: back to the ABCs – Trauma Surgery & Acute Care Open

Diretrizes sobre o tratamento da dissecção de aorta tipo B.

28 Jan, 2022 | 15:33h

The Society of Thoracic Surgeons/American Association for Thoracic Surgery Clinical Practice Guidelines on the Management of Type B Aortic Dissection – Annals of Thoracic Surgery

Comunicado de imprensa: New practice guideline addresses diagnosis, treatment of type B aortic dissection – The Society of Thoracic Surgeons

Edição especial: medicina de vítimas em massa e anestesia.

28 Jan, 2022 | 15:32h

Editoriais:

Mass casualty medicine: time for a 21st century refresh

Exercising for mass casualty preparedness

Massive transfusion and severe blood shortages: establishing and implementing predictors of futility

Transfusion support during mass casualty events

Embracing uncertainty in mass casualty incidents

Pre-hospital critical care at major incidents

Provision of pre-hospital medical care for terrorist attacks

Higher pre-hospital anaesthesia case volumes result in lower mortality rates: implications for mass casualty care

Improving mass casualty planning in low resource settings: Médecins Sans Frontières and International Committee of the Red Cross perspective

Global lessons learned from COVID-19 mass casualty incidents

Reimagining health preparedness in the aftermath of COVID-19

Preparing for mass casualty events despite COVID-19

Anestesia pediátrica:

Paediatric patients in mass casualty incidents: a comprehensive review and call to action

Adaptations to practice and resilience in a paediatric major trauma centre during a mass casualty incident

Cuidado pré-hospitalar:

Injury scoring systems for blast injuries: a narrative review

Association between case volume and mortality in pre-hospital anaesthesia management: a retrospective observational cohort

Establishing quality indicators for pre-hospital advanced airway management: a modified nominal group technique consensus process

Pre-hospital continuous positive airway pressure after blast lung injury and hypovolaemic shock: a modelling study

Preparo:

Review of the requirements for effective mass casualty preparedness for trauma systems. A disaster waiting to happen?

Learning from terrorist mass casualty incidents: a global survey

Refining mass casualty plans with simulation-based iterative learning

Incidentes específicos:

Mass casualty, intentional vehicular trauma and anaesthesia

Chemical, biological, radiological, and nuclear mass casualty medicine: a review of lessons from the Salisbury and Amesbury Novichok nerve agent incidents

Correspondência:

Pre-hospital oral transmucosal fentanyl citrate for trauma analgesia: preliminary experience and implications for civilian mass casualty response

Implications for trauma system development in a low- and middle-income country: the Sri Lanka 2019 Easter Sunday terrorist attack

Development and evaluation of a mass casualty medicine simulation method using figurines

Influx! A game-based learning tool for in-hospital interprofessional disaster preparedness and response

Estudo randomizado | CPAP melhora os desfechos em pacientes com insuficiência respiratória hipoxêmica aguda decorrente de COVID-19, mas cateter nasal de alto fluxo não é melhor que a oxigenoterapia convencional.

25 Jan, 2022 | 15:10h

Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19: The RECOVERY-RS Randomized Clinical Trial – JAMA

Editorial: Defining Optimal Respiratory Support for Patients With COVID-19 – JAMA

 

Comentário no Twitter

 

Nova diretriz de parada cardiorrespiratória leva em conta as variantes de COVID-19 mais contagiosas em meio a uma pandemia em evolução.

25 Jan, 2022 | 15:08h

Comunicado de imprensa: New CPR guidance addresses more contagious COVID-19 variants amidst evolving pandemic – American Heart Association

Ver diretriz: 2022 Interim Guidance to Healthcare Providers for Basic and Advanced Cardiac Life Support in Adults, Children, and Neonates with Suspected or Confirmed COVID-19: From the Emergency Cardiovascular Care Committee and Get With the Guidelines®-Resuscitation Adult and Pediatric Task Forces of the American Heart Association in Collaboration with the American Academy of Pediatrics, American Association for Respiratory Care, The Society of Critical Care Anesthesiologists, and American Society of Anesthesiologists

Estudo randomizado | Fentanil vs. placebo com cetamina e rocurônio para pacientes submetidos à sequência rápida de intubação no departamento de emergência.

25 Jan, 2022 | 14:42h

Fentanyl versus placebo with ketamine and rocuronium for patients undergoing rapid sequence intubation in the emergency department: the FAKT study – a randomized clinical trial – Academic Emergency Medicine (link para o resumo – $ para o texto completo)

Diretriz atualizada | Medicamentos e agentes biológicos recomendados para pacientes adultos com COVID-19.

25 Jan, 2022 | 12:04h

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19 – Covid-19 Advisory for Ontario

 

Comentário no Twitter (fio – clique para saber mais)

 

Guia para imunoterapia na COVID-19.

25 Jan, 2022 | 11:57h

A guide to immunotherapy for COVID-19 – Nature Medicine

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.